Table 3.
Comparison of laboratory tests in patients with COVID-19 on admission to hospital
| Item (unit, normal range) | Overall (n=207) | Ordinary group (n=144) | Severe/critical group (n=63) | p Value |
|---|---|---|---|---|
| Chest CT abnormalities | ||||
| Any typical abnormalities | 191 (92.3%) | 129 (89.6%) | 62 (98.4%) | 0.003 |
| Consolidation | 41 (19.8%) | 3 3(22.9%) | 8 (12.9%) | < 0.001 |
| Ground-glass opacity | 89 (43.0%) | 71 (49.3%) | 18 (29.0%) | < 0.001 |
| Mixed ground-glass opacity and consolidation | 38 (18.4%) | 6 (4.2%) | 32 (51.6%) | < 0.001 |
| Crazy-paving pattern | 22 (10.6%) | 20 (13.9%) | 2 (3.2%) | < 0.001 |
| Air bronchogram | 29 (14%) | 8 (5.6%) | 21 (33.9%) | 0.717 |
| Bilateral involvement | 163 (78.7%) | 101 (70.1%) | 62 (98.4%) | < 0.001 |
| Peripheral distribution | 125 (60.4%) | 95 (66.0%) | 30 (48.4%) | < 0.001 |
| Isolated lower lobe involvement | 51 (24.6%) | 40 (27.8%) | 11 (17.7%) | < 0.001 |
| Chest X-ray abnormalities | Overall (n=88) | Ordinary group (n=57) | Severe/critical group (n=31), | P Value |
| Any typical abnormalities | 81 (92.0%) | 53 (93.0%) | 28 (90.3%) | < 0.001 |
| Consolidation | 13 (14.8%) | 3 (5.2%) | 10 (32.3%) | < 0.001 |
| Ground-glass opacity | 21 (23.9%) | 10 (17.5%) | 11 (35.5%) | < 0.001 |
| Bilateral involvement | 78 (88.6%) | 54 (94.7%) | 31 (100%) | 0.561 |
| Peripheral distribution | 7 (8.0%) | 4 (7.0%) | 3 (9.7%) | 0.341 |
| Isolated lower lobe involvement | 11 (12.5%) | 5 (8.8%) | 6 (19.4%) | < 0.001 |